Rankings
▼
Calendar
INVA Q4 2019 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$76M
-4.9% YoY
Gross Profit
$76M
100.0% margin
Operating Income
$74M
96.9% margin
Net Income
$46M
60.5% margin
EPS (Diluted)
$0.42
QoQ Revenue Growth
+15.5%
Cash Flow
Operating Cash Flow
$67M
Free Cash Flow
$67M
Stock-Based Comp.
$488,000
Balance Sheet
Total Assets
$725M
Total Liabilities
$383M
Stockholders' Equity
$313M
Cash & Equivalents
$278M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$76M
$80M
-4.9%
Gross Profit
$76M
$80M
-4.9%
Operating Income
$74M
$77M
-4.6%
Net Income
$46M
$264M
-82.6%
← FY 2019
All Quarters
Q1 2020 →